- •Foreword
- •Preface
- •Contents
- •About the Editors
- •Contributors
- •1: Tracheobronchial Anatomy
- •Trachea
- •Introduction
- •External Morphology
- •Internal Morphology
- •Mucous Layer
- •Blood Supply
- •Anatomo-Clinical Relationships
- •Bronchi
- •Main Bronchi
- •Bronchial Division
- •Left Main Bronchus (LMB)
- •Right Main Bronchus (RMB)
- •Blood Supply
- •References
- •2: Flexible Bronchoscopy
- •Introduction
- •History
- •Description
- •Indications and Contraindications
- •Absolute Contraindications
- •Procedure Preparation
- •Technique of FB Procedure
- •Complications of FB Procedure
- •Basic Diagnostic Procedures
- •Bronchoalveolar Lavage (BAL)
- •Transbronchial Lung Biopsy (TBLB)
- •Transbronchial Needle Aspiration (TBNA)
- •Bronchial Brushings
- •Advanced Diagnostic Bronchoscopy
- •EBUS-TBNA
- •Ultrathin Bronchoscopy
- •Transbronchial Lung Cryobiobsy (TBLC)
- •Therapeutic Procedures Via FB
- •LASER Bronchoscopy
- •Electrocautery
- •Argon Plasma Coagulation (APC)
- •Cryotherapy
- •Photodynamic Therapy
- •Airway Stent Placement
- •Endobronchial Valve Placement
- •Conclusion
- •References
- •History and Historical Perspective
- •Indications and Contraindications
- •Procedure Description
- •Procedure Planning
- •Target Approximation
- •Sampling
- •Complications
- •Future Directions
- •Summary and Recommendations
- •References
- •4: Rigid Broncoscopy
- •Innovations
- •Ancillary Equipment
- •Rigid Bronchoscopy Applications
- •Laser Bronchoscopy
- •Tracheobronchial Prosthesis
- •Transbronchial Needle Aspiration (TBNA)
- •Rigid Bronchoscope in Other Treatments for Bronchial Obstruction
- •Mechanical Debridement
- •Pediatric Rigid Bronchoscopy
- •Tracheobronchial Dilatation
- •Foreign Bodies Removal
- •Other Indications
- •Complications
- •The Procedure
- •Some Conclusions
- •References
- •History and Historical Perspective
- •Indications and Contraindications
- •Preprocedural Evaluation and Preparation
- •Physical Examination
- •Procedure-Related Indications
- •Application of the Technique
- •Topical Anesthesia
- •Anesthesia of the Nasal Mucosa and Nasopharynx
- •Anesthesia of the Mouth and Oropharynx
- •Superior Laryngeal Nerve Block
- •Recurrent Laryngeal Nerve Block (RLN)
- •Conscious Sedation
- •Monitored Anesthesia Care (MAC)
- •General Anesthesia
- •Monitoring the Depth of Anesthesia
- •Interventional Bronchoscopy Suites
- •Airway Devices
- •Laryngeal Mask Airway (LMA)
- •Endotracheal Tube (ETT)
- •Rigid Bronchoscope
- •Modes of Ventilation
- •Spontaneous Ventilation
- •Assisted Ventilation
- •Noninvasive Positive Pressure Ventilation (NIV)
- •Positive Pressure Controlled Mechanical Ventilation
- •Jet Ventilation
- •Electronic Mechanical Jet Ventilation
- •Postprocedure Care
- •Special Consideration
- •Anesthesia for Peripheral Diagnostic and Therapeutic Bronchoscopy
- •Anesthesia for Interventional Bronchoscopic Procedures During the COVID-19 Pandemic
- •Summary and Recommendations
- •Conclusion
- •References
- •Background
- •Curricular Structure and Delivery
- •What Is a Bronchoscopy Curriculum?
- •Tradition, Teaching Styles, and Beliefs
- •Using Assessment Tools to Guide the Educational Process
- •The Ethics of Teaching
- •When Learners Teach: The Journey from Novice to Mastery and Back Again
- •The Future Is Now
- •References
- •Interventional Procedure
- •Assessment of Flow–Volume Curve
- •Dyspnea
- •Analysis of Pressure–Pressure Curve
- •Conclusions
- •References
- •Introduction
- •Adaptations of the IP Department
- •Environmental Control
- •Personal Protective Equipment
- •Procedure Performance
- •Bronchoscopy in Intubated Patients
- •Other Procedures in IP Unit
- •References
- •Introduction
- •Safety
- •Patient Safety
- •Provider Safety
- •Patient Selection and Screening
- •Lung Cancer Diagnosis and Staging
- •Inpatients
- •COVID-19 Clearance
- •COVID Clearance: A Role for Bronchoscopy
- •Long COVID: A Role for Bronchoscopy
- •Preparing for the Next Pandemic
- •References
- •Historical Perspective
- •Indications and Contraindications
- •Evidence-Based Review
- •Summary and Recommendations
- •References
- •Introduction
- •Clinical Presentation
- •Diagnosis
- •Treatment
- •History and Historical Perspectives
- •Indications and Contraindications
- •Benign and Malignant Tumors
- •Tumors with Uncertain Prognosis
- •Application of the Technique
- •Evidence Based Review
- •Summary and Recommendations
- •References
- •12: Cryotherapy and Cryospray
- •Introduction
- •Historical Perspective
- •Equipment
- •Cryoadhesion
- •Indications
- •Cryorecanalization
- •Cryoadhesion and Foreign Body Removal
- •Cryoadhesion and Mucus Plugs/Blood Clot Retrieval
- •Endobronchial Cryobiopsy
- •Transbronchial Cryobiopsy for Lung Cancer
- •Safety Concerns and Contraindications
- •Cryoablation
- •Indications
- •Evidence
- •Safety Concerns and Contraindications
- •Cryospray
- •Indications
- •Evidence
- •Safety Concerns and Contraindications
- •Advantages of Cryotherapy
- •Limitations
- •Future Research Directions
- •References
- •13: Brachytherapy
- •History and Historical Perspective
- •Indications and Contraindications
- •Application of the Technique
- •Evidence-Based Review
- •Adjuvant Treatment
- •Palliative Treatment
- •Complications
- •Summary and Recommendations
- •References
- •14: Photodynamic Therapy
- •Introduction
- •Photosensitizers
- •First-Generation Photosensitizers
- •M-Tetrahidroxofenil Cloro (mTHPC) (Foscan®)
- •PDT Reaction
- •Tumor Damage Process
- •Procedure
- •Indications
- •Curative PDT Indications
- •Palliative PDT Indications
- •Contraindications
- •Rationale for Use in Early-Stage Lung Cancer
- •Rationale
- •PDT in Combination with Other Techniques for Advanced-Stage Non-small Cell Lung Cancer
- •Commentary
- •Complementary Endoscopic Methods for PDT Applications
- •New Perspectives
- •Other PDT Applications
- •Conclusions
- •References
- •15: Benign Airways Stenosis
- •Etiology
- •Congenital Tracheal Stenosis
- •Iatrogenic
- •Infectious
- •Idiopathic Tracheal Stenosis
- •Distal Bronchial Stenosis
- •Diagnosis Methods
- •Patient History
- •Imaging Techniques
- •Bronchoscopy
- •Pulmonary Function Test
- •Treatment
- •Endoscopic Treatment
- •Dilatation
- •Laser Therapy
- •Stents
- •How to Proceed
- •Stent Placement
- •Placing a Montgomery T Tube
- •The Rule of Twos for Benign Tracheal Stenosis (Fig. 15.23)
- •Surgery
- •Summary and Recommendations
- •References
- •16: Endobronchial Prostheses
- •Introduction
- •Indications
- •Extrinsic Compression
- •Intraluminal Obstruction
- •Stump Fistulas
- •Esophago-respiratory Fistulas (ERF)
- •Expiratory Central Airway Collapse
- •Physiologic Rationale for Airway Stent Insertion
- •Stent Selection Criteria
- •Stent-Related Complications
- •Granulation Tissue
- •Stent Fracture
- •Migration
- •Contraindications
- •Follow-Up and Patient Education
- •References
- •Introduction
- •Overdiagnosis
- •False Positives
- •Radiation
- •Risk of Complications
- •Lung Cancer Screening Around the World
- •Incidental Lung Nodules
- •Management of Lung Nodules
- •References
- •Introduction
- •Minimally Invasive Procedures
- •Mediastinoscopy
- •CT-Guided Transthoracic Biopsy
- •Fluoroscopy-Guided Transthoracic Biopsies
- •US-Guided Transthoracic Biopsy
- •Thoracentesis and Pleural Biopsy
- •Thoracentesis
- •Pleural Biopsy
- •Surgical or Medical Thoracoscopy
- •Image-Guided Pleural Biopsy
- •Closed Pleural Biopsy
- •Image-Guided Biopsies for Extrathoracic Metastases
- •Tissue Acquisition, Handling and Processing
- •Implications of Tissue Acquisition
- •Guideline Recommendations for Tissue Acquisition in Mediastinal Staging
- •Methods to Overcome Challenges in Tissue Acquisition and Genotyping
- •Rapid on-Site Evaluation (ROSE)
- •Sensitive Genotyping Assays
- •Liquid Biopsy
- •Summary, Recommendations and Highlights
- •References
- •History
- •Data Source and Methodology
- •Tumor Size
- •Involvement of the Main Bronchus
- •Atelectasis/Pneumonitis
- •Nodal Staging
- •Proposal for the Revision of Stage Groupings
- •Small Cell Lung Cancer (SCLC)
- •Discussion
- •Methodology
- •T Descriptors
- •N Descriptors
- •M Descriptors
- •Summary
- •References
- •Introduction
- •Historical Perspective
- •Fluoroscopy
- •Radial EBUS Mini Probe (rEBUS)
- •Ultrasound Bronchoscope (EBUS)
- •Virtual Bronchoscopy
- •Trans-Parenchymal Access
- •Cone Beam CT (CBCT)
- •Lung Vision
- •Sampling Instruments
- •Conclusions
- •References
- •History and Historical Perspective
- •Narrow Band Imaging (NBI)
- •Dual Red Imaging (DRI)
- •Endobronchial Ultrasound (EBUS)
- •Optical Coherence Tomography (OCT)
- •Indications and Contraindications
- •Confocal Laser Endomicroscopy and Endocytoscopy
- •Raman Spectrophotometry
- •Application of the Technique
- •Supplemental Technology for Diagnostic Bronchoscopy
- •Evidence-Based Review
- •Summary and Recommendations, Highlight of the Developments During the Last Three Years (2013 on)
- •References
- •Introduction
- •History and Historical Perspective
- •Endoscopic AF-OCT System
- •Preclinical Studies
- •Clinical Studies
- •Lung Cancer
- •Asthma
- •Airway and Lumen Calibration
- •Obstructive Sleep Apnea
- •Future Applications
- •Summary
- •References
- •23: Endobronchial Ultrasound
- •History and Historical Perspective
- •Equipment
- •Technique
- •Indication, Application, and Evidence
- •Convex Probe Ultrasound
- •Equipment
- •Technique
- •Indication, Application, and Evidence
- •CP-EBUS for Malignant Mediastinal or Hilar Adenopathy
- •CP-EBUS for the Staging of Non-small Cell Lung Cancer
- •CP-EBUS for Restaging NSCLC After Neoadjuvant Chemotherapy
- •Complications
- •Summary
- •References
- •Introduction
- •What Is Electromagnetic Navigation?
- •SuperDimension Navigation System (EMN-SD)
- •Computerized Tomography
- •Computer Interphase
- •The Edge Catheter: Extended Working Channel (EWC)
- •Procedural Steps
- •Planning
- •Detecting Anatomical Landmarks
- •Pathway Planning
- •Saving the Plan and Exiting
- •Registration
- •Real-Time Navigation
- •SPiN System Veran Medical Technologies (EMN-VM)
- •Procedure
- •Planning
- •Navigation
- •Biopsy
- •Complications
- •Limitations
- •Summary
- •References
- •Introduction
- •Image Acquisition
- •Hardware
- •Practical Considerations
- •Radiation Dose
- •Mobile CT Studies
- •Future Directions
- •Conclusion
- •References
- •26: Robotic Assisted Bronchoscopy
- •Historical Perspective
- •Evidence-Based Review
- •Diagnostic Yield
- •Monarch RAB
- •Ion Endoluminal Robotic System
- •Summary
- •References
- •History and Historical Perspective
- •Indications and Contraindications
- •General
- •Application of the Technique
- •Preoperative Care
- •Patient’s Position and Operative Field
- •Incision and Initial Dissection
- •Palpation
- •Biopsy
- •Control of Haemostasis and Closure
- •Postoperative Care
- •Complications
- •Technical Variants
- •Extended Cervical Mediastinoscopy
- •Mediastinoscopic Biopsy of Scalene Lymph Nodes
- •Inferior Mediastinoscopy
- •Mediastino-Thoracoscopy
- •Video-Assisted Mediastinoscopic Lymphadenectomy
- •Transcervical Extended Mediastinal Lymphadenectomy
- •Evidence-Based Review
- •Summary and Recommendations
- •References
- •Introduction
- •Case 1
- •Adrenal and Hepatic Metastases
- •Brain
- •Bone
- •Case 1 Continued
- •Biomarkers
- •Case 1 Concluded
- •Case 2
- •Chest X-Ray
- •Computerized Tomography
- •Positive Emission Tomography
- •Magnetic Resonance Imaging
- •Endobronchial Ultrasound with Transbronchial Needle Aspiration
- •Transthoracic Needle Aspiration
- •Transbronchial Needle Aspiration
- •Endoscopic Ultrasound with Needle Aspiration
- •Combined EUS-FNA and EBUS-TBNA
- •Case 2 Concluded
- •Case 3
- •Standard Cervical Mediastinoscopy
- •Extended Cervical Mediastinoscopy
- •Anterior Mediastinoscopy
- •Video-Assisted Thoracic Surgery
- •Case 3 Concluded
- •Case 4
- •Summary
- •References
- •29: Pleural Anatomy
- •Pleural Embryonic Development
- •Pleural Histology
- •Cytological Characteristics
- •Mesothelial Cells Functions
- •Pleural Space Defense Mechanism
- •Pleura Macroscopic Anatomy
- •Visceral Pleura (Pleura Visceralis or Pulmonalis)
- •Parietal Pleura (Pleura Parietalis)
- •Costal Parietal Pleura (Costalis)
- •Pleural Cavity (Cavitas Thoracis)
- •Pleural Apex or Superior Pleural Sinus [12–15]
- •Anterior Costal-Phrenic Sinus or Cardio-Phrenic Sinus
- •Posterior Costal-Phrenic Sinus
- •Cost-Diaphragmatic Sinus or Lateral Cost-Phrenic Sinus
- •Fissures18
- •Pleural Vascularization
- •Parietal Pleura Lymphatic Drainage
- •Visceral Pleura Lymphatic Drainage
- •Pleural Innervation
- •References
- •30: Chest Ultrasound
- •Introduction
- •The Technique
- •The Normal Thorax
- •Chest Wall Pathology
- •Pleural Pathology
- •Pleural Thickening
- •Pneumothorax
- •Pulmonary Pathology
- •Extrathoracic Lymph Nodes
- •COVID and Chest Ultrasound
- •Conclusions
- •References
- •Introduction
- •History of Chest Tubes
- •Overview of Chest Tubes
- •Contraindications for Chest Tube Placement
- •Chest Tube Procedural Technique
- •Special Considerations
- •Pneumothorax
- •Empyema
- •Hemothorax
- •Chest Tube Size Considerations
- •Pleural Drainage Systems
- •History of and Introduction to Indwelling Pleural Catheters
- •Indications and Contraindications for IPC Placement
- •Special Considerations
- •Non-expandable Lung
- •Chylothorax
- •Pleurodesis
- •Follow-Up and IPC Removal
- •IPC-Related Complications and Management
- •Competency and Training
- •Summary
- •References
- •32: Empyema Thoracis
- •Historical Perspectives
- •Incidence
- •Epidemiology
- •Pathogenesis
- •Clinical Presentation
- •Radiologic Evaluation
- •Biochemical Analysis
- •Microbiology
- •Non-operative Management
- •Prognostication
- •Surgical Management
- •Survivorship
- •Summary and Recommendations
- •References
- •Evaluation
- •Initial Intervention
- •Pleural Interventions for Recurrent Symptomatic MPE
- •Especial Circumstances
- •References
- •34: Medical Thoracoscopy
- •Introduction
- •Diagnostic Indications for Medical Thoracoscopy
- •Lung Cancer
- •Mesothelioma
- •Other Tumors
- •Tuberculosis
- •Therapeutic Indications
- •Pleurodesis of Pneumothorax
- •Thoracoscopic Drainage
- •Drug Delivery
- •Procedural Safety and Contraindications
- •Equipment
- •Procedure
- •Pre-procedural Preparations and Considerations
- •Procedural Technique [32]
- •Medical Thoracoscopy Versus VATS
- •Conclusion
- •References
- •Historical Perspective
- •Indications and Contraindications
- •Evidence-Based Review
- •Endobronchial Valves
- •Airway Bypass Tracts
- •Coils
- •Other Methods of ELVR
- •Summary and Recommendations
- •References
- •36: Bronchial Thermoplasty
- •Introduction
- •Mechanism of Action
- •Trials
- •Long Term: Ten-Year Study
- •Patient Selection
- •Bronchial Thermoplasty Procedure
- •Equipment
- •Pre-procedure
- •Bronchoscopy
- •Post-procedure
- •Conclusion
- •References
- •Introduction
- •Bronchoalveolar Lavage (BAL)
- •Technical Aspects of BAL Procedure
- •ILD Cell Patterns and Diagnosis from BAL
- •Technical Advises for Conventional TLB and TLB-C in ILD
- •Future Directions
- •References
- •Introduction
- •The Pediatric Airway
- •Advanced Diagnostic Procedures
- •Endobronchial Ultrasound
- •Virtual Navigational Bronchoscopy
- •Cryobiopsy
- •Therapeutic Procedures
- •Dilation Procedures
- •Thermal Techniques
- •Mechanical Debridement
- •Endobronchial Airway Stents
- •Metallic Stents
- •Silastic Stents
- •Novel Stents
- •Endobronchial Valves
- •Bronchial Thermoplasty
- •Discussion
- •References
- •Introduction
- •Etiology
- •Congenital ADF
- •Malignant ADF
- •Cancer Treatment-Related ADF
- •Benign ADF
- •Iatrogenic ADF
- •Diagnosis
- •Treatment Options
- •Endoscopic Techniques
- •Stents
- •Clinical Results
- •Stent Complications
- •Other Available Stents
- •Other Endoscopic Methods
- •References
- •Introduction
- •Anatomy and Physiology of Swallowing
- •Functional Physiology of Swallowing
- •Epidemiology and Risk Factors
- •Types of Foreign Bodies
- •Organic
- •Inorganic
- •Mineral
- •Miscellaneous
- •Clinical Presentation
- •Acute FB
- •Retained FB
- •Radiologic Findings
- •Bronchoscopy
- •Airway Management
- •Rigid Vs. Flexible Bronchoscopy
- •Retrieval Procedure
- •Instruments
- •Grasping Forceps
- •Baskets
- •Balloons
- •Suction Instruments
- •Ablative Therapies
- •Cryotherapy
- •Laser Therapy
- •Electrocautery and APC
- •Surgical Management
- •Complications
- •Bleeding and Hemoptysis
- •Distal Airway Impaction
- •Iron Pill Aspiration
- •Follow-Up and Sequelae
- •Conclusion
- •References
- •Vascular Origin of Hemoptysis
- •History and Historical Perspective
- •Diagnostic Bronchoscopy
- •Therapeutic Bronchoscopy
- •General Measures
- •Therapeutic Bronchoscopy
- •Evidence-Based Review
- •Summary
- •Recommendations
- •References
- •History
- •“The Glottiscope” (1807)
- •“The Esophagoscope” (1895)
- •The Rigid Bronchoscope (1897–)
- •The Flexible Bronchoscope (1968–)
- •Transbronchial Lung Biopsy (1972) (Fig. 42.7)
- •Laser Therapy (1981–)
- •Endobronchial Stents (1990–)
- •Electromagnetic Navigation (2003–)
- •Bronchial Thermoplasty (2006–)
- •Endobronchial Microwave Therapy (2004–)
- •American Association for Bronchology and Interventional Pulmonology (AABIP) and Journal of Bronchology and Interventional Pulmonology (JOBIP) (1992–)
- •References
- •Index
118 |
F. Guedes and A. Bugalho |
|
|
Adaptations of the IP Department |
Environmental Control |
Each IP unit must implement infection-control programs and rethink its administrative, environmental, logistic, and procedural circuits [10], as well as the type and timing of procedures to perform and personal protection equipment (PPE).
Administrative andOrganizational Issues
Administrative and organizational measures are crucial to assure safety while maintaining activity [10].
All referrals and requests to the IP unit must be made preferably by telephone or digital means. Patients should be contacted by telephone 24–72 h prior to arrival to the IP unit and submitted to a pre-screening checklist that includes questions about recent symptoms suggestive of COVID-19; contact with suspicious/con rmed SARS-CoV-2 cases; or occupational exposure.
•\ The elective procedure in patients who have recent respiratory and infectious symptoms and/or chest imaging suggestive of COVID-19 should be postponed and rescheduled after all symptoms are solved.
•\ All patients must be asked for respiratory symptoms and temperature checked when arrived at IP unit.
•\ All patients should have at least one negative RT-PCR for SARS-CoV-2 in the hours/days preceding the exam (most hospitals recommend in the previous 24–48 h). In patients with a positive RT-PCR SARS-CoV-2, the decision to proceed with the intervention will be based on the procedure emergence (Flowchart 8.1 and Table 8.1).
•\ The IP unit should keep a record of deferred patients to reschedule their procedures according to the COVID-19 outbreak situation, as proposed in Table 8.2.
It is crucial to plan and correctly prepare the physical space of the IP unit [4].
•\ All areas of the IP unit should separate con-rmed/high-risk patients from negative/ low-risk ones. This must include reception, administrative, clinical, and waiting rooms. Inpatients and outpatients should be separated, either by time or physical location, to prevent cross infection.
•\ Speci c circuits and written workfow plans must be prepared, covering the pre-proce- dural area, procedural room, post-procedural area, decontamination, and reprocessing. It is recommended the implementation of a fowchart with different areas and walking paths using a color visual zone system: red zone for contaminated areas and green zone for non- COVID-19 safe areas [11] (Fig. 8.1a).
•\ All items required for PPE should be stored in a de ned and separated place inside the unit.
•\ A designated area in the unit should be selected, close to the procedural suite, for wearing and removal of all PPE, according to hospital protocol and standards, to reduce exposure to contaminated particles and droplets. When an anteroom is available, it may be used as an area for donning and dof ng of PPE (Fig. 8.1b).
•\ Stations should be created to facilitate frequent hand hygiene.
•\ Waste containers should be distributed according to local infectious control recommendations.
•\ Posters and other visual aids should be placed at strategic locations around the intervention suite to act as reminders.
•\ Emergent procedures must be, if possible, performed in a negative pressure room environment, preferably under airway-controlled protection (e.g., laryngeal mask, endotracheal tube).
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
8 Interventional Procedures During the COVID-19 Pandemics: Adaptations in the Interventional… |
119 |
|
|
a
b
Fig. 8.1 (a) Implementation of speci c circuits with color visual zone system to distinguish contaminated (red) and safe cleaned areas (green). (b) Designated area for donning and dof ng of PPE
120 |
F. Guedes and A. Bugalho |
|
|
Assess emergency of the procedure
(TABLE 1)
URGENT
Confirmed or suspected
SARS-CoV-2 infection?
YES |
NO |
Revise indication Revise alternative methods
Proceed with full PPE TABLE2
Preferably at patient bedside / dedicated ICU / COVID Ward
Recovery onsite or dedicated COVID unit within the institution
Perform SARS-CoV-2 test
POSITIVE
INDETERMINATE NEGATIVE
NOT AVAILABLE
AT THE TIME OF
PROCEDURE
Proceed with full PPE TABLE2
Recovery onsite
NON-URGENT
Perform SARS-CoV-2 test, assess symptoms and contact exposure
|
|
|
|
|
|
|
|
|
|
|
|
POSITIVE / HIGH |
|
|
NEGATIVE / LOW |
||
RISK |
|
|
RISK |
||
|
|
|
|
|
|
|
|
|
|
|
|
Postpone and conduct |
|
|
patient to local COVID 19 |
|
|
circuit or transfer to |
|
|
|
Proceed with |
|
referral institution |
|
|
|
|
full PPE |
Evaluate clinical evolution |
|
TABLE2 |
and reassess fitness for |
|
Recovery onsite |
procedure |
|
|
Reschedule according |
|
|
|
|
|
to priority |
|
|
TABLE1 |
|
|
|
|
|
Flowchart 8.1 Proposed triage of IP procedures during the COVID-19 outbreak. (Adapted from F. Guedes et al., Recommendations for interventional pulmonology during
COVID-19 outbreak: a consensus statement from the Portuguese Pulmonology Society)
•\ Elective procedures should be reserved for COVID-19 negative patients (Flowchart 8.1 and Table 8.1).
•\ Even in COVID-19 negative patients, procedures should be performed in a dedicated negative pressure room (see below, ventilation requirement) with strict isolation precautions and adequate ventilation to avoid aerosol contamination [12]. If these requirements are not met in the bronchoscopy suite, they should be then sought in a different venue, such as an operating theatre, isolation room, or ICU with negative pressure, if available.
•\ If negative pressure rooms are unavailable throughout the institution, a speci c and dedicated room with adequate natural ventilation (see requirement below) may be an alternative [6].
•\ Suspicious and con rmed cases of COVID-19 must be placed in an airborne infection isolation room with negative pressure before and after the procedure.
•\ Low-risk and negative patients can remain in the pre-procedural and recovery area, if there is adequate room ventilation, protective equipment (e.g., surgical mask), and physical distance (>2 m) from other negative patients.
•\ Patient source control strategies, such as wearing a mask and keeping a safety distance should be encouraged.
•\ Whenever feasible, it is recommended to perform procedures in a room that meets the ventilation requirements for airborne infection isolation (AII), ensuring the dilution and removal of contaminated air. The preferred
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
8 Interventional Procedures During the COVID-19 Pandemics: Adaptations in the Interventional… |
121 |
|||
|
|
|
||
Table 8.1 Type and prioritization of IP procedures |
|
|
||
|
|
|
|
|
Risk |
SARS-CoV-2 |
|
|
|
strati cation |
status |
Procedure indication |
|
|
Urgent |
COVID-19 |
• Massive hemoptysis with airway compromise |
|
|
procedures |
negative or |
• Acute foreign body aspiration |
|
|
|
positive |
• Severe symptomatic central airway obstruction |
|
|
|
|
• Suspicion of alternative (non-COVID-19) acute and severe infectious disease |
|
|
|
|
• Airway management of dif cult and nondelayable endotracheal intubation or |
|
|
|
|
complicated percutaneous tracheotomy |
|
|
|
|
• Large and symptomatic pleural occupation (air, fuid, blood, pus) |
|
|
|
COVID-19 |
• Removal of copious secretions and mucus plugs |
|
|
|
positive or |
• Possibility of superinfection (community acquired or nosocomial) |
|
|
|
high risk |
• Severe suspicious cases of COVID-19 that need to be con rmed by |
|
|
|
|
bronchoscopy after negative/inconclusive nasopharyngeal RT-PCR SARS-CoV-2 |
||
|
|
tests |
|
|
Nonurgent |
COVID-19 |
Nondelayable (2–4 weeks) |
• Lung cancer diagnosis and staging |
|
procedures |
negative or |
|
• Increased mediastinal and/or hilar lymph nodes |
|
|
low-risk |
|
• Suspected pulmonary infection in |
|
|
|
|
immunosuppressed hosts |
|
|
|
|
• Suspicion of pulmonary tuberculosis (after |
|
|
|
|
negative sputum) |
|
|
|
|
• Interstitial lung disease in symptomatic and lung |
|
|
|
|
function deteriorating patients |
|
|
|
|
• Mild-to-moderate airway stenosis |
|
|
|
|
• Mild persistent hemoptysis |
|
|
|
|
• Pleurodesis or indwelling pleural catheter |
|
|
|
|
placement for recurrent and symptomatic pleural |
|
|
|
|
effusion |
|
|
|
|
|
|
|
|
Delayable (≥4 weeks) |
• Routine evaluation of tracheobronchial stenosis |
|
|
|
|
or endobronchial stent |
|
|
|
|
• Surveillance of lung transplant patients |
|
|
|
|
• Mild asymptomatic benign airway stenosis |
|
|
|
|
• Minor pulmonary CT abnormalities in an |
|
|
|
|
asymptomatic patient |
|
|
|
|
• Chronic cough evaluation (normal chest CT and |
|
|
|
|
lung function) |
|
|
|
|
• Interstitial lung disease differential diagnosis in |
|
|
|
|
nonsymptomatic or nondeteriorating patients |
|
|
|
|
• Bronchoscopic lung volume reduction |
|
|
|
|
• Bronchial thermoplasty |
|
|
|
|
• Minimal pleural effusion in asymptomatic |
|
|
|
|
patients |
|
system is a negative pressure room with at least 12 air changes per hour (ACH) with airfow direction control (single-pass or recirculation systems with HEPA ltration). Alternatively, natural ventilation with an airfow of at least 160 L/s is an option [11].
•\ Between procedures, it must be ensured that adequate time for air renewal is allowed (depending on ACH and disinfection methods, but at least 30 min). Local adaptations must be considered according to the characteristics of the IP unit.
Concerning cleaning and disinfection of the environment and equipment:
•\ Recommendations from the Centres for Disease Control and Prevention (CDC) on reprocessing equipment should be followed. These include precleaning, leak testing, manual cleaning, and visual inspection followed by disinfection/sterilization. A high-level disinfection, either manually or using an automated endoscope reprocessor is recommended.